<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2021</study_start_year><condition>Colorectal cancer</condition><disease>Colorectal Cancer</disease><study_type>Observational</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2660056</full_dataset_link><location>Japan</location><study_start_month>4</study_start_month><repository>ECRIN MDR</repository><study_status>Completed</study_status></additional><is_claimable>false</is_claimable><name>The exploratory study to evaluate the association between efficacy of bevacizumab combination therapy and pretreatment plasma vascular endothelial growth factor-D levels in metastatic colorectal cancer (GI-SCREEN-CRC-Ukit additional study 01)</name><description>Primary outcome(s): To evaluate the association between plasma VEGF-D levels and the efficacy of bevacizumab combination therapy in patients with colorectal cancer.</description><dates><creation>2021-04-15</creation></dates><accession>2660056</accession><cross_references><Japan Primary Registries Network>JPRN-UMIN000043800</Japan Primary Registries Network></cross_references></HashMap>